Neurodevelopmental Disorder Caused by Deletion of , a lncRNA Gene.

N Engl J Med

From the Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (V.S.G., M.C.O., J.K.G., K.V.G., E.E., B.W., F.A., D.G.M., A.O.-L.), and the Department of Neurology, Brigham and Women's Hospital

Published: October 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

encodes a human long noncoding RNA (lncRNA) adjacent to , a coding gene in which de novo loss-of-function variants cause developmental and epileptic encephalopathy. Here, we report our findings in three unrelated children with a syndromic, early-onset neurodevelopmental disorder, each of whom had a de novo deletion in the locus. The children had severe encephalopathy, shared facial dysmorphisms, cortical atrophy, and cerebral hypomyelination - a phenotype that is distinct from the phenotypes of patients with haploinsufficiency. We found that the deletion results in increased CHD2 protein abundance in patient-derived cell lines and increased expression of the transcript in . These findings indicate that has bidirectional dosage sensitivity in human disease, and we recommend that other lncRNA-encoding genes be evaluated, particularly those upstream of genes associated with mendelian disorders. (Funded by the National Human Genome Research Institute and others.).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11826417PMC
http://dx.doi.org/10.1056/NEJMoa2400718DOI Listing

Publication Analysis

Top Keywords

neurodevelopmental disorder
8
disorder caused
4
caused deletion
4
deletion lncrna
4
lncrna gene
4
gene encodes
4
encodes human
4
human long
4
long noncoding
4
noncoding rna
4

Similar Publications

Purpose: The study aims to assess familial and environmental characteristics and daily routines (nutrition, sleep, and screen time) associated with attention-deficit/hyperactivity disorder (ADHD) in Turkish children and compare them with typically developing peers.

Methods: A case-control study was conducted with 106 ADHD-diagnosed children and 100 typically developing peers. Data were analyzed using descriptive statistics and logistic regression models to determine risk factors for ADHD.

View Article and Find Full Text PDF

Background: Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) often face structural and psychological barriers in accessing medical care, including economic costs, long wait times, and stress of attending new medical environments. The COVID-19 pandemic accelerated the adoption of telehealth services to overcome these challenges. However, few studies have assessed the satisfaction levels of children and adolescents diagnosed with neurodevelopmental disorders and their caregivers when they use telepsychiatry, particularly in Japan.

View Article and Find Full Text PDF

Background: Fetal alcohol spectrum disorder (FASD) is a lifelong neurodevelopmental condition resulting from prenatal alcohol exposure (PAE) during gestation. Conservative estimates of FASD prevalence in United States children are 1%-5%. Early identification could facilitate early intervention, yet fewer than 1% of children with FASD receive a diagnosis.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants and young children. The COVID-19 pandemic significantly disrupted global RSV epidemiology. This study aimed to investigate the impact of the pandemic on RSV epidemiology in northern Taiwan from 2018 to 2023.

View Article and Find Full Text PDF

Genetic modifiers of epilepsy: A narrative review.

Mol Cell Neurosci

September 2025

Department of Personalized & Molecular Medicine, Era University, Lucknow, India.

Epilepsy is a neurological disorder that shows strong genetic control on the timing and onset of symptoms and drug response variability. Some epilepsy syndromes have clear monogenic mutations but genes with control on the phenotype and severity of the disorder and drug sensitivity are present in the whole genetic profile. Genetic modifiers are not the cause of epilepsy but control significant networks such as synaptic plasticity and ion channels and neurodevelopment and neuroinflammation and therefore the reason why two individuals with the same primary mutations have different clinical courses.

View Article and Find Full Text PDF